HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Philadelphia Rx Fraud Investigations Have New Chief; Are SEC Cases Next?

Executive Summary

The Philadelphia U.S. Attorney's selection of Virginia Gibson to succeed Jim Sheehan as its Civil Division chief suggests continuity in the office's prescription drug fraud and kickback investigations

Related Content

Medco SEC Filing For Spin-Off Included “False Statement” On Audit – DoJ Suit
Compliance Officers Make Good “Whistleblowers” – U.S. Prosecutor Sheehan
SEC’s Busy Week: Schering Notified Of Potential Suit; Waksal Expands Plea
King Medicaid Rebate Data Sought By SEC; Subpoena Includes Altace Rebates
AstraZeneca Self-Markets Nolvadex Generic; Zoladex Settlement Near
DoJ joins SEC in looking at Bristol
Forest Excels: Celexa, Lexapro Help Company In Down Quarter On Wall Street
ADR Cases Could Be Prosecuted Under Kickback Statute – U.S. Atty Sheehan
Elan Meltdown May End R&D Joint Ventures As Funding Vehicle For Biotech
AstraZeneca Zoladex Marketing Practices Under Investigation By DoJ



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts